The dose-limiting factor in essentially all curative radiotherapy is d
amage to normal tissue. In spite of this, our understanding of radiati
on-induced damage to normal tissue leaves much to be desired. Damage t
o the rectum is often observed after clinical brachytherapy of pelvic
malignancies. A model in which the rectum of the rat is irradiated wit
h a uniform and reproducible dose of brachytherapy irradiation was dev
eloped. This system consists of an intracavitary applicator, which is
used in conjunction with methods that reduce fecal flow, a jacket that
restrains rat movement and a lead-shielded chamber to contain rats du
ring low-dose-rate brachytherapy. Irradiation was applied in 48-h inte
rvals separated by 48-h breaks during which the applicator was removed
. Methods to analyze the sequelae of brachytherapy irradiation of the
rectum were also developed. The total dose of 0.75 Gy/h continuous low
-dose-rate brachytherapy required to produce obstruction in the rat re
ctum has been measured. The ED(50) was 70.6 +/- 4.2 Gy. The length of
time between irradiation and obstruction was also correlated with tota
l dose. Other effects on the rectum that were related to dose were dia
rrhea and rectovaginal fistula. This irradiation system can produce un
iform and reliable brachytherapy doses to the rat rectum. The late eff
ects in normal tissues observed in this model are similar to those obs
erved in humans after irradiation of the rectum. The model should be a
ppropriate for analyzing relative changes in the rectum resulting from
different dose rates and fractionation schemes relevant to brachyther
apy. (C) 1996 by Radiation Research Society